{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:54:18Z","timestamp":1783140858819,"version":"3.54.6"},"publisher-location":"New York, NY","reference-count":18,"publisher":"Springer US","isbn-type":[{"value":"9781071645864","type":"print"},{"value":"9781071645871","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4587-1_14","type":"book-chapter","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:07:45Z","timestamp":1749809265000},"page":"125-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Methods for Evaluation of Antivirals and Neutralizing Antibodies Against Tick-Borne Encephalitis Virus"],"prefix":"10.1007","author":[{"given":"Ludek","family":"Eyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Svoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Palus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Salat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"R\u016f\u017eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","volume":"164","author":"D Ruzek","year":"2019","unstructured":"Ruzek D et al (2019) Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res 164:23\u201351","journal-title":"Antiviral Res"},{"issue":"47","key":"14_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2807\/1560-7917.ES.2019.24.47.1900658","volume":"24","author":"M Holding","year":"2019","unstructured":"Holding M et al (2019) Detection of new endemic focus of tick-borne encephalitis virus (TBEV), Hampshire\/Dorset border, England. Euro Surveill 24(47):24","journal-title":"Euro Surveill"},{"issue":"1","key":"14_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3201\/eid2601.191085","volume":"26","author":"M Holding","year":"2020","unstructured":"Holding M et al (2020) Tick-borne encephalitis virus, United Kingdom. Emerg Infect Dis 26(1):90\u201396","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"14_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2020.101606","volume":"12","author":"W Fares","year":"2021","unstructured":"Fares W et al (2021) Tick-borne encephalitis virus in Ixodes ricinus (Acari: Ixodidae) ticks, Tunisia. Ticks Tick Borne Dis 12(1):101606","journal-title":"Ticks Tick Borne Dis"},{"issue":"5","key":"14_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.12998\/wjcc.v3.i5.430","volume":"3","author":"P Bogovic","year":"2015","unstructured":"Bogovic P, Strle F (2015) Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J Clin Cases 3(5):430\u2013441","journal-title":"World J Clin Cases"},{"issue":"7","key":"14_CR6","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/microorganisms9071420","volume":"9","author":"B Kohlmaier","year":"2021","unstructured":"Kohlmaier B et al (2021) Clinical characteristics of patients with tick-borne encephalitis (TBE): a European multicentre study from 2010 to 2017. Microorganisms 9(7):1420","journal-title":"Microorganisms"},{"key":"14_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105504","volume":"210","author":"L Eyer","year":"2023","unstructured":"Eyer L, Seley-Radtke K, Ruzek D (2023) New directions in the experimental therapy of tick-borne encephalitis. Antiviral Res 210:105504","journal-title":"Antiviral Res"},{"issue":"21","key":"14_CR8","doi-asserted-by":"publisher","first-page":"e01028","DOI":"10.1128\/JVI.01028-17","volume":"91","author":"L Eyer","year":"2017","unstructured":"Eyer L et al (2017) Escape of tick-borne Flavivirus from 2'-C-methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness. J Virol 91(21):e01028","journal-title":"J Virol"},{"issue":"16","key":"14_CR9","doi-asserted-by":"publisher","first-page":"e00367","DOI":"10.1128\/JVI.00367-19","volume":"93","author":"L Eyer","year":"2019","unstructured":"Eyer L et al (2019) An E460D substitution in the NS5 protein of tick-borne encephalitis virus confers resistance to the inhibitor Galidesivir (BCX4430) and also attenuates the virus for mice. J Virol 93(16):e00367","journal-title":"J Virol"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.antiviral.2016.07.018","volume":"133","author":"L Eyer","year":"2016","unstructured":"Eyer L et al (2016) Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus. Antiviral Res 133:119\u2013129","journal-title":"Antiviral Res"},{"issue":"9","key":"14_CR11","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1128\/AAC.00807-15","volume":"59","author":"L Eyer","year":"2015","unstructured":"Eyer L et al (2015) Nucleoside inhibitors of tick-borne encephalitis virus. Antimicrob Agents Chemother 59(9):5483\u20135493","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"14_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1021\/ml400226s","volume":"4","author":"DI Osolodkin","year":"2013","unstructured":"Osolodkin DI et al (2013) Inhibitors of tick-borne flavivirus reproduction from structure-based virtual screening. ACS Med Chem Lett 4(9):869\u2013874","journal-title":"ACS Med Chem Lett"},{"key":"14_CR13","first-page":"243","volume-title":"Annual reports in medicinal chemistry","author":"D Ruzek","year":"2022","unstructured":"Ruzek D (2022) Animal models of tick-borne encephalitis for preclinical antiviral research. In: Annual reports in medicinal chemistry, pp 243\u2013256"},{"issue":"5","key":"14_CR14","doi-asserted-by":"publisher","first-page":"e20210236","DOI":"10.1084\/jem.20210236","volume":"218","author":"M Agudelo","year":"2021","unstructured":"Agudelo M et al (2021) Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease. J Exp Med 218(5):e20210236","journal-title":"J Exp Med"},{"issue":"29","key":"14_CR15","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1016\/j.vaccine.2014.05.012","volume":"32","author":"IK Baykov","year":"2014","unstructured":"Baykov IK et al (2014) A protective chimeric antibody to tick-borne encephalitis virus. Vaccine 32(29):3589\u20133594","journal-title":"Vaccine"},{"issue":"32","key":"14_CR16","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1016\/j.vaccine.2010.05.060","volume":"28","author":"LN Levanov","year":"2010","unstructured":"Levanov LN et al (2010) Chimeric antibodies against tick-borne encephalitis virus. Vaccine 28(32):5265\u20135271","journal-title":"Vaccine"},{"issue":"4","key":"14_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215075","volume":"14","author":"AL Matveev","year":"2019","unstructured":"Matveev AL et al (2019) Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus. PLoS One 14(4):e0215075","journal-title":"PLoS One"},{"issue":"2","key":"14_CR18","doi-asserted-by":"publisher","first-page":"e01522","DOI":"10.1128\/AAC.01522-20","volume":"65","author":"L Eyer","year":"2021","unstructured":"Eyer L et al (2021) Broad-Spectrum antiviral activity of 3'-Deoxy-3'-Fluoroadenosine against emerging Flaviviruses. Antimicrob Agents Chemother 65(2):e01522","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Methods in Molecular Biology","Tick-Borne Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4587-1_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T10:07:46Z","timestamp":1749809266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4587-1_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071645864","9781071645871"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4587-1_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"14 June 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}